Screening Patients With Sickle Cell Disease for Kidney Damage

NCT02239016 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 320

Last updated 2021-03-29

No results posted yet for this study

Summary

This study aims to study the temporal course of sickle nephropathy and assess novel biomarkers that can predict patients prone to nephropathy.

Conditions

Sponsors & Collaborators

  • Children's Hospital Medical Center, Cincinnati

    lead OTHER

Principal Investigators

  • Punam Malik, MD · Children's Hospital Medical Center, Cincinnati

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2019-07-29
Completion
2020-07-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02239016 on ClinicalTrials.gov